•  
  •  
 

Document Type

Original Article

Abstract

Background: The fully implantable indwelling catheter known as port-cath, port-a-cath, or simply port, which offers high insertion success rates, is now the technology of choice for this use. Fully implanted catheters can be introduced through the superior vena cava system by catheterizing deep or superficial veins. Aim: Comparing the outcomes of jugal portacath or basilic portacath insertion in terms of its benefits, drawbacks, efficacy, and patency in an effort to select the approach with the fewest complications. Subject and Methods: Thirty patients in the department of vascular surgery at Al- Azhar University Hospitals in Cairo participated in this prospective, randomised trial. Results: The majority of individuals had rectal and colon cancer, however there was no discernible difference in any primary tumour analysed between the two groups of patients. Between the two groups, there were no appreciable differences in Hb, PLT, INR, PT, or PTT. There is a considerable disparity between the two groups in terms of hospital stays. The majority of patients experienced thrombi, but there was no difference in either group's outcomes that could be seen. Conclusion: The current study revealed that Juglar port-a-cath and basilic port-a-cath approaches were safe and effective CVC for chemotherapy. Both techniques were comparable as regard length of hospital stay and complication rate. Medical professionals can choose the best CVC for long-term chemotherapy based on their experience, the characteristics, and preferences of the patients.

Keywords

Jugular port-a-cath, Basilic port-a-cath, Chemotherapy

Subject Area

General Surgery

Download

Included in

Surgery Commons

Share

COinS